Categories: HealthcareNews

Novillus Launches Curate: A Unified Approach to Chart Abstraction for Quality and Risk Adjustment.

PORTLAND, Ore., Feb. 11, 2025 /PRNewswire/ — Novillus, a leader in healthcare technology solutions, today announced the launch of Curate, an AI-powered chart abstraction solution designed to transform chart abstraction and review for Payers. Curate unifies quality and risk adjustment into a single workflow, enabling plans to close multiple gap types in one seamless review process—significantly improving efficiency, accuracy, and scalability.

Novillus’ AI-powered Curate transforms chart abstraction for health plans, unifying quality and risk into one workflow.

By combining HIPAA-compliant artificial intelligence with Novillus’ extensive healthcare expertise, Curate doubles chart review capacity for validators, enhances measure accuracy to 95% or higher, and significantly reduces wasted validator time—achieving an average 77% reduction in unnecessary chart reviews. Unlike traditional solutions, Curate works at scale across both quality and risk gaps, identifying evidence for multiple gap types in a single processing run.

“As the complexity of quality and risk adjustment programs grows, traditional methods of chart review are no longer sustainable. Curate offers a transformative approach—eliminating redundancy, improving accuracy, and streamlining operations at scale,” said Harlan Edlin, president at Novillus. “By unifying quality and risk workflows, we empower health plans to efficiently identify, validate, and close multiple gaps in a single pass—driving both compliance and financial performance.”

Curate: A Unified Approach to Chart Abstraction for Risk and Quality

Curate seamlessly integrates into existing workflows, allowing health plans to scale chart review operations, enhance quality reporting, and optimize risk adjustment performance—all without disrupting current processes. By unifying quality and risk gap identification into a single-pass workflow, Curate eliminates inefficiencies and enables payers to:

  • Eliminate redundant chart reviews by consolidating quality and risk validation.
  • Expand validator capacity without increasing headcount.
  • Achieve 95%+ measure accuracy, leading to improved quality scores and compliance.
  • Scale operations effortlessly while maintaining data integrity and compliance.

With Curate, health plans can accelerate performance improvements across both quality and risk adjustment—reducing inefficiencies while improving accuracy, compliance, and financial outcomes.

For more information about Curate and to request a demo, visit Novillus.com/ai-chart-review.

About Novillus

Novillus is a leading healthcare technology platform that drives efficiency in health plan operations while increasing performance revenue. Our comprehensive approach helps health plans increase Risk Adjustment scores, Star Ratings and Provider Data Accuracy.

Media Contact: media@novillus.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novillus-launches-curate-a-unified-approach-to-chart-abstraction-for-quality-and-risk-adjustment-302373404.html

SOURCE Novillus

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

9 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

12 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

12 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

12 hours ago